Rakesh N. Veedu is an Associate Professor and head of the precision nucleic acid theranostics group at Murdoch University and the Perron Institute for Neurological and Translational Science. He obtained his PhD in synthetic organic chemistry in 2006 from the University of Queensland, Australia under the supervision of Prof. Curt Wentrup after completing his MSc from Griffith University, Australia. He then continued his postdoctoral career under the supervision of Prof. Jesper Wengel at the Nucleic Acid Center, University of Southern Denmark in the field of nucleic acid chemical biology. Later in 2009, he was appointed as a Research Associate Professor within the Nucleic Acid Center. He then returned to The University of Queensland in mid-2010 and established his independent research career in functional nucleic acid theranostics development. His current research is focused on developing novel precision nucleic acid theranostics for tackling solid cancers, neurological diseases including Alzheimer's disease and infectious diseases using nucleic acid aptamers, antisense oligonucleotides, siRNA, antimiRs, molecular beacons and DNAzymes.
Research Keywords & Expertise
Aptamers
MiRNA
SiRNA
Antisense oligonucleot...
DNAzymes
Triplex forming oligon...
Chemically-modified ol...
Oligonucleotide delive...
Fingerprints
49%
Antisense oligonucleotides
38%
Aptamers
12%
DNAzymes
6%
MiRNA
5%
SiRNA
5%
Chemically-modified oligonucleotides
5%
Oligonucleotide delivery
Short Biography
Rakesh N. Veedu is an Associate Professor and head of the precision nucleic acid theranostics group at Murdoch University and the Perron Institute for Neurological and Translational Science. He obtained his PhD in synthetic organic chemistry in 2006 from the University of Queensland, Australia under the supervision of Prof. Curt Wentrup after completing his MSc from Griffith University, Australia. He then continued his postdoctoral career under the supervision of Prof. Jesper Wengel at the Nucleic Acid Center, University of Southern Denmark in the field of nucleic acid chemical biology. Later in 2009, he was appointed as a Research Associate Professor within the Nucleic Acid Center. He then returned to The University of Queensland in mid-2010 and established his independent research career in functional nucleic acid theranostics development. His current research is focused on developing novel precision nucleic acid theranostics for tackling solid cancers, neurological diseases including Alzheimer's disease and infectious diseases using nucleic acid aptamers, antisense oligonucleotides, siRNA, antimiRs, molecular beacons and DNAzymes.